Intranasal stimulation for treatment of meibomian gland disease and blepharitis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 16, 2021
Grant Date -
Nov 2, 2017
app pub date -
May 2, 2017
filing date -
May 2, 2016
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully